Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;117:876-885
Published online before print February 4, 2008, doi: 10.1161/CIRCULATIONAHA.107.728147
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Circulation: February 19, 2008, Volume 117, Number 7
Right arrow All Versions of this Article:
117/7/876    most recent
CIRCULATIONAHA.107.728147v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mehta, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mehta, R. H.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Coronary Artery Bypass Surgery
Related Collections
Right arrow CV surgery: coronary artery disease
Right arrowRelated Article

(Circulation. 2008;117:876-885.)
© 2008 American Heart Association, Inc.


Cardiovascular Surgery

Clinical Characteristics and In-Hospital Outcomes of Patients With Cardiogenic Shock Undergoing Coronary Artery Bypass Surgery

Insights From the Society of Thoracic Surgeons National Cardiac Database

Rajendra H. Mehta, MD, MS; Joshua D. Grab, MS; Sean M. O’Brien, PhD; Donald D. Glower, MD; Constance K. Haan, MD, MS; James S. Gammie, MD; Eric D. Peterson, MD, MPH, on Behalf of the Society of Thoracic Surgeons National Cardiac Database Investigators

From the Duke Clinical Research Institute (R.H.M., J.D.G., S.M.O., E.D.P.) and Duke University Medical Center (R.H.M., D.D.G., E.D.P.), Durham, NC; University of Florida (C.K.H.), Jacksonville; and University of Maryland (J.S.G.), Baltimore.

Correspondence to Rajendra H. Mehta, MD, Box 17969, Duke Clinical Research Institute, Durham, NC 27715. E-mail mehta007{at}dcri.duke.edu

Received July 21, 2007; accepted December 7, 2007.

Background— There exist few studies that characterize contemporary clinical features and outcomes or risk factors for operative mortality in cardiogenic shock (CS) patients undergoing coronary artery bypass grafting (CABG).

Methods and Results— We evaluated data of 708 593 patients with and without CS undergoing CABG enrolled in the Society of Thoracic Surgeons National Cardiac Database (2002–2005). Clinical, angiographic, and operative features and in-hospital outcomes were evaluated in patients with and without CS. Logistic regression was used to identify predictors of operative mortality and to estimate weights for an additive risk score. Patients with preoperative CS constituted 14 956 (2.1%) of patients undergoing CABG yet accounted for 14% of all CABG deaths. Operative mortality in CS patients was high and surgery specific, rising from 20% for isolated CABG to 33% for CABG plus valve surgery and 58% for CABG plus ventricular septal repair. Although mortality for CABG surgery overall declined significantly over time (P for trend <0.0001), mortality for CS patients undergoing CABG did not change significantly during the 4-year study period (P=0.07). Factors associated with higher death risk for CS patients undergoing CABG were identified by multivariable analysis and summarized into a simple bedside risk score (c statistic=0.74) that accurately stratified those with low (<10%) to very high (>60%) mortality risk.

Conclusions— Patients with CS represent a minority of those undergoing CABG yet have persistently high operative risks, accounting for 14% of deaths in CABG patients. Estimation of patient-specific risk of mortality is feasible with the simplified additive risk tool developed in our study with the use of routinely available preprocedural data.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2008 117: 857-859. [Extract] [Full Text]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
D. H. Adams, A. C. Anyanwu, J. Chikwe, and F. Filsoufi
The Year in Cardiovascular Surgery
J. Am. Coll. Cardiol., June 23, 2009; 53(25): 2389 - 2403.
[Full Text] [PDF]


Home page
JAMAHome page
MEND-CABG II Investigators*
Efficacy and Safety of Pyridoxal 5'-Phosphate (MC-1) in High-Risk Patients Undergoing Coronary Artery Bypass Graft Surgery: The MEND-CABG II Randomized Clinical Trial
JAMA, April 16, 2008; 299(15): 1777 - 1787.
[Abstract] [Full Text] [PDF]